Candel Therapeutics
CADL
CADL
78 hedge funds and large institutions have $117M invested in Candel Therapeutics in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 14 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less capital invested
Capital invested by funds: $120M → $117M (-$3.16M)
5% less funds holding
Funds holding: 82 → 78 (-4)
20% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 20
Holders
78
Holding in Top 10
2
Calls
$4.56M
Puts
$1.21M
Top Buyers
| 1 | +$5.91M | |
| 2 | +$3.81M | |
| 3 | +$2.77M | |
| 4 |
ACA
Acorn Capital Advisors
New York
|
+$2.2M |
| 5 |
Two Sigma Investments
New York
|
+$1.9M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$1.19M | |
| 3 | -$1.18M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$546K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$540K |